Exosens
EXENS.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.19 | -0.00 | 2.76 | -0.25 |
| FCF Yield | 1.15% | 2.91% | 1.24% | 0.88% |
| EV / EBITDA | 38.74 | 21.57 | 29.84 | 14.66 |
| Quality | ||||
| ROIC | 4.54% | 5.20% | 3.35% | 7.25% |
| Gross Margin | 61.96% | 22.70% | 95.55% | 82.50% |
| Cash Conversion Ratio | 1.60 | 1.70 | 7.79 | 2.10 |
| Growth | ||||
| Revenue 3-Year CAGR | 118.85% | 8,563,342.26% | 8,047,231.39% | 7,574,735.98% |
| Free Cash Flow Growth | -2.65% | 83.90% | 145.89% | 4,561.74% |
| Safety | ||||
| Net Debt / EBITDA | 3.11 | 3.18 | 3.39 | 4.86 |
| Interest Coverage | 6.83 | 5.90 | 1.42 | 1.66 |
| Efficiency | ||||
| Inventory Turnover | 0.81 | 1.72 | 1.42 | 1.45 |
| Cash Conversion Cycle | 112.68 | 68.48 | 74.92 | 89.60 |